Peer-reviewedCC BYAntibiotics (Basel, Switzerland)
Caenorhabditis elegans as an In Vivo Infection–Rescue Model for Early-Stage Antimicrobial Screening Against Gram-Positive and Gram-Negative Bacteria
- 1Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, AB T2N 4N1, Canada; (S.M.); (J.-A.M.); (J.M.C.)
Related
- Eleven-Year Trends in Antimicrobial Resistance and Isolation Rates per 1000 Patient-Days of Key Gram-Positive and Gram-Negative Bacteria in a Tertiary Care Hospital in Türkiye (2014–2024)
- Multisite clinical evaluation of the iFAST rapid antimicrobial susceptibility test direct from positive blood cultures containing gram-negative organisms
- Family screening for genetic cardiomyopathies in ECG-positive phenotype-negative adolescents: a joint clinical and genetic approach.
- Clinical Outcomes After Recovered, Positive, and Negative Pulse Oximetry Screening Results Among Newborns
- Exploring Chemical Diversity Alongside Antioxidant, Antimicrobial, Antiproliferative, Anti-Inflammatory, and Caenorhabditis elegans Locomotor Responses in Whole, Caps and Stipes of Suillus luteus and Agaricus bisporus
BibTeX
@article{mirza2026caenorhabditis,
title = {{Caenorhabditis elegans as an In Vivo Infection–Rescue Model for Early-Stage Antimicrobial Screening Against Gram-Positive and Gram-Negative Bacteria}},
author = {Salman Mirza and Jo-Ann McClure and John M. Conly and Kunyan Zhang},
journal = {Antibiotics (Basel, Switzerland)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13700891},
note = {CC BY},
}
RIS
TY - JOUR
TI - Caenorhabditis elegans as an In Vivo Infection–Rescue Model for Early-Stage Antimicrobial Screening Against Gram-Positive and Gram-Negative Bacteria
AU - Salman Mirza
AU - Jo-Ann McClure
AU - John M. Conly
AU - Kunyan Zhang
PY - 2026
DA - 2026/09/23
JO - Antibiotics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13700891
SN - 2079-6382
ER -